Healthcare Sector News

This week we run our value metrics over the US mid and large cap sectors to see which stocks are looking undervalued.

CoreWeave cuts deal with Open AI ahead of anticipated IPO, Hinge Health files in New York and Venture Global craters.

Which Canadian stocks look like they can weather the trade war with the US while still providing investors with a decent return in 2025?

The Worldwide Healthcare Trust celebrates 30 years this year but it's the next 30 years that look really exciting

One Health to transition from Aquis to AIM in March seeking greater liquidity as raises £8m to build its first surgical hub

Tristel sees strong performance as it continues to focus on opening up new high-growth overseas markets under new CEO Matt Sassone

Feedback hopes capital reorganisation and new funding will help flagship product, Bleepa's penetration into NHS. Buoyed by inclusion in ERF.

Scientists in Cambridge have developed a new ‘super test’ for prostate cancer in an effort to revolutionise screening and diagnosis.

Avon Protection looks like one of the best quality stocks on the LSE at the moment, driven partly by fund manager love.

Association of Investment Companies' members tip healthcare, technology and North America as the best-performing sectors for 2025

We take a closer look at Spectrum X, a UK biotech company which could list next year, and is currently taking on pre-IPO investment.

This week we are tipping a China-based pioneer in healthcare devices which you can wear to keep track of essential readings.

One Health Group improves earnings and expects to exceed its previous year-end forecast following resolution of the NHS junior doctors' strike

Fresh from our tour of Japan, we look at five of the top large cap stocks currently trading on the Tokyo Stock Exchange.

The integration of AI into drug discovery is reshaping the biotech and healthcare landscape. Here's how you can invest in these advancements

Tecan Group's share price continues to fall, but is this true of the rest of the healthcare sector in Switzerland?

Concerns still swirl around the Cerebras IPO due to the absence of the big tech banks, while London gets ready for Applied Nutrition.

Perimeter Medical Imaging has a major sugar daddy but investors have been worried about his commitment to the stock: is he still on board?

Ryan Reynolds' ad company sits down with Morgan Stanley to talk IPO plans, while a $200m healthcare SPAC hits the market.

Stocks of vaccine makers and manufacturers of testing equipment surge as mpox virus spreads in central Africa.

AQSE-listed cosmetics group Incanthera said it has radically expanded the size of its initial skincare launch in Europe.

On this podcast, Paul Major, Investment Manager of Bellevue Healthcare Trust talks to Stuart Fieldhouse about the Healthcare sector

This week we are buying a US large cap health insurance specialist which is using technology to deliver a better experience for customers.

Intuitive Investment Group follows a high conviction-led investment strategy which has yielded one-year returns of 120%

Tristel reports highest sales and profit in its thirty-year history, including during COVID, when demand for its products was unprecedented.

Oscillate implementing its turnaround strategy, cutting costs, streamlining its investment portfolio and focusing on special situations

This Nordic healthcare provider is arguably one of the biggest and best in the region - can its shares start to reflect that in 2024?

French surgeons complete the implant operation for a CARMAT artificial heart which offers a solution for cardiac tumours patients

Moonfare investors are approaching the New Year cautiously and have continued to diversify into the various private investments it offers.

UK-listed Incanthera has secured a major distribution deal for Switzerland and Austria for its proprietary skincare products.

The Armchair Trader tries to predict what the top five investment sectors will be for 2024. Will they be 'hot' or 'not'?

Moves towards further legalisation of cannabis-based medical products have put the European industry in a prime position.

Oxford BioDynamics advanced precision medicine testing to transform cancer care and provide doctors with the tools they need

Tristel beats analyst expectations and looks forward to its strongest outlook for 30 years as products gain regulatory approval in America

Gooch and Housego expecting revenues and profits for full year to be ahead of market expectations despite contraction in order book

Ilika dispatches first revenue-generating micro-battery samples as partnership develops with US meditech manufacturer, Cirtec Medical

We take a look at five of the best healthcare sector stocks in the UK, based off their fundamentals and peer analysis.

US listed managed care company, Molina Healthcare is on the rader this week following a shift in market sentiment

New CEO takes the helm at cutting edge AI-driven med-tech venture backed by Social Capital's Chamath Palihapitiya.

We met with what we consider to be a game changing US listed healthcare tech company, developing new imaging solutions for cancer treatment.

TT Electronics maintains strong momentum into 2023, but experiencing supply chain issues and the effect of inflation on components

The European stocks universe is full of some excellent opportunities in the healthcare sector: we love this French device manufacturer.

We carry out a deep dive on Aquis Stock Exchange listed UK healthcare provider One Health which is helping the UK to cut into waiting lists

Spectral MD moving forward on US federal contract to supply AI-driven burns diagnosis equipment as part of BARDA programme

We take our first look at this developer of proprietary and frankly revolutionary technology to support cancer surgeons.

With many analysts expecting a recession in 2023, we look at some of the sectors which could still do well next year.

Haleon has a lot going for it in the wake of its de-merger from GSK, but can the management team deliver value to investors?

NMC Healthcare heads off attempt by Noor Capital to get Dubai court to enforce a judgement of debt in its favour.

We look at the data underpinning the solid rise in this large cap healthcare technology stock, which we are buying this week.

We caught up with the management team at Psyence Group just ahead of their announced Phase II trials in the UK.